Serological Transplant Diagnostics Market
Serological Transplant Diagnostics Market Analysis By Product (Reagents & Accessories, Systems), By Application (Kidney, Liver, Heart, Lung Transplantation), By Distribution Channel & By Region - Global Market Insights 2021-2031
Analysis of Serological Transplant Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Serological Transplant Diagnostics Market Outlook (2021-2031)
The global serological transplant diagnostics market size is gaining traction and likely to ascend at around 2.5% CAGR during the forecast period of 2021 to 2031. While advancements in the medical & diagnostic sector are playing a vital role in raising the market value for serological transplant diagnostics, growing awareness regarding proper diagnosis remains another key growth factor.
The growth potential of the market will be propelled by mergers and acquisitions involving smaller specialized hospitals and Tier-1 hospitals. This trend is anticipated to enhance the value of the serological transplant diagnostics market over the predicted timeframe. Consequently, the demand for transplant diagnostic products, assays, and kits is expected to rise, driven by the increasing number of individuals seeking healthcare services from larger hospitals. These acquisitions also facilitate training opportunities for medical personnel, including physicians and nurses.
Regional players across North America, Europe, and Asia Pacific are set to witness impressive growth over the coming years, while rise in requirement from hospitals and other key distribution channels will further cater market growth in future.
A new study by Fact.MR provides thorough analysis of the global serological transplant diagnostics market, along with insights of key driving & restraining factors, demand-supply trajectories, and new trends around the globe for the forecast period of 2021 to 2031.
The report tracks the industry in 20+high-growth markets, and also details how the COVID-19 pandemic is shaping market growth.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Historical & Future Market Outlook
Serological transplant diagnosis, being a highly significant part of successful and efficient organ transplantation, has gained rapid traction over the past years.
Growth in key distribution channels such as hospitals and organ transplantation centers, to name a few, has further raised demand during the last 5 years from 2016 to 2020, which, in turn, has attracted more stakeholders to this industry.
Rise in cases of serious lung, liver, and kidney diseases, and medical & diagnostic advancements, are fuelling the sales of serological transplant diagnostic equipment.
Additionally, various initiatives taken by leading health organizations such as the WHO (World Health Organization), CDC (Centers for Disease Control and Prevention), and others are aiding the growth of suppliers in this industry.
According to Fact.MR, the global serological transplant diagnostics market is set to expand at around 2.5% CAGR through 2031.
How is Rising Need for Organ Transplants Aiding Demand for Serological Transplant Diagnostics?
Prevalence of organ damage cases has substantially raised the demand for serological transplant diagnostic solutions since the past decade. According to a report published by the National Kidney Foundation, over 2 million people across the world currently receive treatment for kidney failure, while a majority are treated in only five countries - the United States, Japan, Germany, Brazil, and Italy.
As per the report, more than 80% of all patients who receive treatment for kidney failure are from affluent countries, with universal access to healthcare and a large elderly population.
As stated in a report titled “The Burden of Lung Diseases”, published by the ERS Organization, respiratory diseases are among the leading causes of death worldwide, while lung infections, lung cancer, and chronic obstructive pulmonary disease (COPD) together account for approximately 10 million deaths yearly. This indicates the rising need serological transplant diagnostic equipment across regions.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Key Challenges Faced by Serology Transplant Diagnostic Equipment Suppliers?
While cases of kidney, heart, lung, and other organ damage are increasing steadily, there is still lack of knowledge and awareness regarding timely diagnosis and receiving proper treatment.
Furthermore, serological transplantation and diagnosis are quite expensive, and hence, not affordable by everyone.
As stated in a report published by NCBI, liver disease accounts for nearly 2 million deaths per year, worldwide. The fatality of liver, kidney, lung, and other organ damage is well-known, but still, organ transplants are yet to be widely adopted by patients who suffer from severe damage.
Manufacturers and suppliers of serological transplant diagnostics are investing their efforts to produce a broader range of affordable products as a solution to this issue.
Country-Wise Analysis
Why is the Serological Transplant Diagnostics Industry Anticipated to Exhibit Hegemony in the U.S.?
The United States is the leading country in North America as far as serological transplant diagnostics is concerned, and will witness impressive rise in demand over the coming years.
Highly advanced medical & diagnostic sectors coupled with rise in cases of severe kidney and heart diseases are fuelling the sales of manufacturers in the country.
As stated in a report titled “Heart Disease Facts”, published by CDC on 8th September 2020, heart disease cost the United States around US$ 219 billion each year from 2014 to 2015, which includes the cost of healthcare services, medicines, and lost productivity due to health.
As per the report, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States, and around 655,000 Americans die from heart disease, including heart damage, each year. As more people are becoming aware regarding the fatality of heart diseases, the rate of organ transplantation is rising in the U.S.
What Enables China to Maintain a Leading Market Position?
China, being the epicenter of the world’s fastest-growing market for serological transplant diagnostics, East Asia, is in the spotlight for manufacturers and suppliers in this industry.
Highly advanced diagnostics industry, and increase in cases of liver, kidney, and lung damage, are raising the revenue of players in in China.
As per data revealed by the China Governmental Statistical Survey, overall rate of survival in brain-dead donor single lung transplantation is more than 60%, while the same for double lung transplantation is more than 75%, as observed over the last 5 years.
This data gives a glimpse of new growth scope awaiting players dealing with serological transplant diagnostics in China.
How Lucrative Would Germany be for Providers of Serology Transplant Diagnostics?
Germany is the dominating country in Europe for serological transplant diagnostics, owing to surge in demand from highly developed hospitals and blood banks & transportation centers.
Additionally, rise in requirement in diverse applications such as liver transplantation, heart transplantation, and kidney transplantation is further catering to growth of the market.
According to a report published by the Germany Trade and Investment (GTAI) Organization, Germany’s healthcare market is number 1 in Europe by volume, number of patients, medical technology manufacturers, and healthcare providers. As per the report, Germany’s hospital industry is highly advanced, while healthcare spending in the country exceeded EUR 400 billion in 2019, and is growing further.
According to a report published by the PLOS Organization on 24th April 2020, in the adult German population, Chronic Kidney Disease (CKD) is estimated to have a prevalence between 2% to 7%, while a majority of CKD patients are classified as stage 3.
This is indirectly contributing to the rise in sales of serological transplant diagnostic equipment across the country.
Do Suppliers of Serological Transplant Diagnostic Equipment Need to Look at India?
India has emerged as another lucrative market for serological transplant diagnostics, and is expected to take its spot in the limelight for suppliers and manufacturers in this industry. Increase in cases of lung, heart, and kidney failure, coupled with steady growth of the healthcare & diagnostics industry is spurring growth in India.
According to a report titled “Chronic Kidney Disease in India”, published by the American Society of Nephrology on 7th May 2018, reported a prevalence of CKD in different regions across India ranges from 1% to 13%.
Recently, data from the International Society of Nephrology’s Kidney Disease Data Centre Study reported a prevalence of 17%, while the etiology of CKD varies considerably throughout India. These statistics give an idea regarding the upcoming opportunities in India for stakeholders in the serological transplant diagnostics space.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Category-Wise Insights
Which Product is Highly Sought-After for Serological Transplant Diagnostics?
According to Fact.MR, reagents & accessories, followed by systems, are dominating the global serological transplant equipment market in terms of product.
Reagents and accessories are an integral part of various types of serological transplant diagnostic tests such as blood type testing, Human Leukocyte Antigens (HLA) testing, and other serological tests, as they are highly useful and crucial for effective organ transplantation.
Which Transplantation Procedures Top the Application List?
Currently, rise in demand for serological transplant diagnosis is becoming more prevalent in applications such as kidney and liver transplantation. Increase in cases of kidney and liver damage is expected to further fuel the sales of manufacturers in this industry.
Some of the other key segments aiding market expansion in this category are heart and lung transplantation.
Rise in Demand from Hospitals to Bolster Market Growth
With steady expansion of hospitals, demand for serological transplant diagnostic equipment is surging around the globe. According to the European Commission (EC), the EU hospitals and healthcare industry is growing fast, while contributing to nearly 2% of EU’s total manufacturing workforce.
Other key distribution channels are blood banks & transplant centers, donor registries, and research laboratories.
Competitive Landscape
The global serological transplant diagnostics market is fragmented in nature and thriving on potential players. In order to capitalize on new opportunities, key market players are diversifying their product portfolios. For instance,
- Recently, Bag Health Care GmbH launched its wide range of serological transplant diagnostic solutions such as bag diagnostics microlymphocytotoxicity test, bag diagnostics histo trays, and others.
- Siemens Healthineers expanded its serological testing domains, including SARS-CoV-2 Testing in 2020, in order to increase its sales footprint.
Report Scope
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
|
Market Segmentation by Category
By Product :
- Reagents & Accessories
- Systems
By Application :
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Others
By Distribution Channel :
- Hospitals
- Blood Banks & Transplant Centres
- Donor Registries & Research Laboratories
By Region :
- North America
- Latin America
- Europe
- Middle East and Africa (MEA)
- East Asia
- South Asia
- Oceania
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. GDP Growth Outlook 4.1.2. Global Healthcare Industry Outlook 4.1.3. Increasing Per Capita Healthcare Spending 4.1.4. Income Per Capita Outlook 4.2. Forecast Factors - Relevance & Impact 4.2.1. An Increase in Awareness Related to Serological Transplantations 4.2.2. Mergers and Acquisitions 4.2.3. Growing Geriatric Population 4.2.4. Rising Number of Soft Tissue, Solid and Stem Cell Based Transplantation 4.2.5. Rising Prevalence of Chronic Diseases 4.2.6. Growth in Robot-Assisted Laboratory Automation of Diagnostic Procedures 4.2.7. Increasing Installation Base of PCR and NGS Instruments 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 5. Market Context 5.1. Key Product Features and Their USPs 5.2. Product Adoption / Usage Analysis 5.3. Key Promotional Strategies, By Manufacturers 5.4. Regulations, By Region 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 financial analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue by Product 6.4.2. Revenue by Application 6.4.3. Revenue by Distribution Channel 6.4.4. Revenue by Country 6.5. 2020 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected recovery Quarter 6.8. Recovery Scenario – Short term, Midterm and Long Term Impact 7. Global Serological Transplant Diagnostics Market Volume (Units) Analysis 2016 – 2020 and Forecast, 2021 – 2031 7.1. Historical Market Volume (Units) Analysis, 2016 – 2020 7.2. Current and Future Market Volume (Units) Projections, 2021 – 2031 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Serological Transplant Diagnostics Market - Pricing Analysis 8.1. Country Pricing Analysis by Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Latin America and Middle East Average Pricing Analysis Benchmark 9. Global Serological Transplant Diagnostics Market Value Analysis 2016 – 2020 and Forecast, 2021 – 2031 9.1. Historical Market Value (US$ Mn) Analysis, 2016 – 2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021 – 2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis by Product, 2016 – 2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2021 – 2031 10.3.1. Reagents & Accessories 10.3.2. Systems 10.4. Market Attractiveness Analysis by Product 11. Global Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis by Application, 2016 – 2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021 – 2031 11.3.1. Kidney Transplantation 11.3.2. Liver Transplantation 11.3.3. Heart Transplantation 11.3.4. Lung Transplantation 11.3.5. Others 11.4. Market Attractiveness Analysis by Application 12. Global Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, By Distribution Channel 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016 – 2020 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021 – 2031 12.3.1. Hospitals 12.3.2. Blood banks & Transplant centres 12.3.3. Donor Registries & Research Laboratories 12.4. Market Attractiveness Analysis by Distribution Channel 13. Global Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis by Region, 2016 – 2020 13.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2021 – 2031 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis by Region 14. North America Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021 – 2031 14.3.1. By Country 14.3.1.1. U.S. 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Application 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Latin America Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 15.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021 – 2031 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. Europe Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 16.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021 – 2031 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. U.K. 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. Rest of Europe 16.3.2. By Product 16.3.3. By Application 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. South Asia Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 17.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021 – 2031 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Application 17.3.4. By Distribution Channel 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. East Asia Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 18.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021 – 2031 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.1.4. Rest of East Asia 18.3.2. By Product 18.3.3. By Application 18.3.4. By Distribution Channel 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Oceania Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 19.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021 – 2031 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Application 19.3.4. By Distribution Channel 19.4. Market Attractiveness Analysis 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 20.1. Introduction 20.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016 – 2020 20.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021 – 2031 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. South Africa 20.3.1.3. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Application 20.3.4. By Distribution Channel 20.4. Market Attractiveness Analysis 20.5. Key Market Participants - Intensity Mapping 20.6. Drivers and Restraints - Impact Analysis 21. Key and Emerging Countries Serological Transplant Diagnostics Market Analysis 2016 – 2020 and Forecast 2021 – 2031 21.1. Introduction 21.1.1. Market Value Proportion Analysis, By Key Countries 21.1.2. Global Vs. Country Growth Comparison 21.2. U.S. Serological Transplant Diagnostics Market Analysis 21.2.1. By Product 21.2.2. By Application 21.2.3. By Distribution Channel 21.3. Canada Serological Transplant Diagnostics Market Analysis 21.3.1. By Product 21.3.2. By Application 21.3.3. By Distribution Channel 21.4. Mexico Serological Transplant Diagnostics Market Analysis 21.4.1. By Product 21.4.2. By Application 21.4.3. By Distribution Channel 21.5. Brazil Serological Transplant Diagnostics Market Analysis 21.5.1. By Product 21.5.2. By Application 21.5.3. By Distribution Channel 21.6. U.K. Serological Transplant Diagnostics Market Analysis 21.6.1. By Product 21.6.2. By Application 21.6.3. By Distribution Channel 21.7. Germany Serological Transplant Diagnostics Market Analysis 21.7.1. By Product 21.7.2. By Application 21.7.3. By Distribution Channel 21.8. France Serological Transplant Diagnostics Market Analysis 21.8.1. By Product 21.8.2. By Application 21.8.3. By Distribution Channel 21.9. Italy Serological Transplant Diagnostics Market Analysis 21.9.1. By Product 21.9.2. By Application 21.9.3. By Distribution Channel 21.10. Spain Serological Transplant Diagnostics Market Analysis 21.10.1. By Product 21.10.2. By Application 21.10.3. By Distribution Channel 21.11. BENELUX Serological Transplant Diagnostics Market Analysis 21.11.1. By Product 21.11.2. By Application 21.11.3. By Distribution Channel 21.12. Russia Serological Transplant Diagnostics Market Analysis 21.12.1. By Product 21.12.2. By Application 21.12.3. By Distribution Channel 21.13. China Serological Transplant Diagnostics Market Analysis 21.13.1. By Product 21.13.2. By Application 21.13.3. By Distribution Channel 21.14. Japan Serological Transplant Diagnostics Market Analysis 21.14.1. By Product 21.14.2. By Application 21.14.3. By Distribution Channel 21.15. South Korea Serological Transplant Diagnostics Market Analysis 21.15.1. By Product 21.15.2. By Application 21.15.3. By Distribution Channel 21.16. India Serological Transplant Diagnostics Market Analysis 21.16.1. By Product 21.16.2. By Application 21.16.3. By Distribution Channel 21.17. ASEAN Serological Transplant Diagnostics Market Analysis 21.17.1. By Product 21.17.2. By Application 21.17.3. By Distribution Channel 21.18. Australia Serological Transplant Diagnostics Market Analysis 21.18.1. By Product 21.18.2. By Application 21.18.3. By Distribution Channel 21.19. New Zealand Serological Transplant Diagnostics Market Analysis 21.19.1. By Product 21.19.2. By Application 21.19.3. By Distribution Channel 21.20. GCC Countries Serological Transplant Diagnostics Market Analysis 21.20.1. By Product 21.20.2. By Application 21.20.3. By Distribution Channel 21.21. Turkey Serological Transplant Diagnostics Market Analysis 21.21.1. By Product 21.21.2. By Application 21.21.3. By Distribution Channel 21.22. South Africa Serological Transplant Diagnostics Market Analysis 21.22.1. By Product 21.22.2. By Application 21.22.3. By Distribution Channel 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies 22.2. Market Concentration 22.3. Market Share Analysis of Top Players 22.4. Market Presence Analysis 22.4.1. By Regional Foot Print of Players 22.4.2. Product Foot Print by Players 22.4.3. Channel Foot Print by Players 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Competition Deep Dive 23.3.1. Beckman Coulter Inc 23.3.2. Overview 23.3.2.1. Product Portfolio 23.3.2.2. Analyst Commentary 23.3.2.3. Key Financials 23.3.2.4. Recent Developments 23.3.2.5. Sales Footprint 23.3.2.6. Strategy Overview 23.3.2.6.1. Marketing Strategy 23.3.2.6.2. Product Strategy 23.3.2.6.3. Channel Strategy 23.3.3. Becton Dickinson & Company 23.3.3.1. Product Portfolio 23.3.3.2. Analyst Commentary 23.3.3.3. Key Financials 23.3.3.4. Recent Developments 23.3.3.5. Sales Footprint 23.3.3.6. Strategy Overview 23.3.3.6.1. Marketing Strategy 23.3.3.6.2. Product Strategy 23.3.3.6.3. Channel Strategy 23.3.4. ThermoFisher Scientific Inc 23.3.4.1. Product Portfolio 23.3.4.2. Analyst Commentary 23.3.4.3. Key Financials 23.3.4.4. Recent Developments 23.3.4.5. Sales Footprint 23.3.4.6. Strategy Overview 23.3.4.6.1. Marketing Strategy 23.3.4.6.2. Product Strategy 23.3.4.6.3. Channel Strategy 23.3.5. Bio-Rad Laboratories Inc 23.3.5.1. Product Portfolio 23.3.5.2. Analyst Commentary 23.3.5.3. Key Financials 23.3.5.4. Recent Developments 23.3.5.5. Sales Footprint 23.3.5.6. Strategy Overview 23.3.5.6.1. Marketing Strategy 23.3.5.6.2. Product Strategy 23.3.5.6.3. Channel Strategy 23.3.6. Agena Bioscience Inc 23.3.6.1. Product Portfolio 23.3.6.2. Analyst Commentary 23.3.6.3. Key Financials 23.3.6.4. Recent Developments 23.3.6.5. Sales Footprint 23.3.6.6. Strategy Overview 23.3.6.6.1. Marketing Strategy 23.3.6.6.2. Product Strategy 23.3.6.6.3. Channel Strategy 23.3.7. Avioq Inc 23.3.7.1. Product Portfolio 23.3.7.2. Analyst Commentary 23.3.7.3. Key Financials 23.3.7.4. Recent Developments 23.3.7.5. Sales Footprint 23.3.7.6. Strategy Overview 23.3.7.6.1. Marketing Strategy 23.3.7.6.2. Product Strategy 23.3.7.6.3. Channel Strategy 23.3.8. Bag Health Care GmbH 23.3.8.1. Product Portfolio 23.3.8.2. Analyst Commentary 23.3.8.3. Key Financials 23.3.8.4. Recent Developments 23.3.8.5. Sales Footprint 23.3.8.6. Strategy Overview 23.3.8.6.1. Marketing Strategy 23.3.8.6.2. Product Strategy 23.3.8.6.3. Channel Strategy 23.3.9. Immucor Inc 23.3.9.1. Product Portfolio 23.3.9.2. Analyst Commentary 23.3.9.3. Key Financials 23.3.9.4. Recent Developments 23.3.9.5. Sales Footprint 23.3.9.6. Strategy Overview 23.3.9.6.1. Marketing Strategy 23.3.9.6.2. Product Strategy 23.3.9.6.3. Channel Strategy 23.3.10. Siemens Healthineers 23.3.10.1. Product Portfolio 23.3.10.2. Analyst Commentary 23.3.10.3. Key Financials 23.3.10.4. Recent Developments 23.3.10.5. Sales Footprint 23.3.10.6. Strategy Overview 23.3.10.6.1. Marketing Strategy 23.3.10.6.2. Product Strategy 23.3.10.6.3. Channel Strategy 23.3.11. Produkte GmbH 23.3.11.1. Product Portfolio 23.3.11.2. Analyst Commentary 23.3.11.3. Key Financials 23.3.11.4. Recent Developments 23.3.11.5. Sales Footprint 23.3.11.6. Strategy Overview 23.3.11.6.1. Marketing Strategy 23.3.11.6.2. Product Strategy 23.3.11.6.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Serological Transplant Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021–2031, By Product
Table 02: Global Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 03: Global Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 04: Global Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
Table 05: Global Serological Transplant Diagnostics Market Value (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Region
Table 06: North America Serological Transplant Diagnostics Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 07: North America Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 08: North America Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 09: North America Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
Table 10: Latin America Serological Transplant Diagnostics Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 11: Latin America Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 12: Latin America Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 13: Latin America Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
Table 14: Europe Serological Transplant Diagnostics Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 15: Europe Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 16: Europe Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 17: Europe Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
Table 18: East Asia Serological Transplant Diagnostics Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 19: East Asia Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 20: East Asia Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 21: East Asia Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
Table 22: South Asia Serological Transplant Diagnostics Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 23: South Asia Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 24: South Asia Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 25: South Asia Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
Table 26: Oceania Serological Transplant Diagnostics Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 27: Oceania Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 28: Oceania Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 29: Oceania Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
Table 30: MEA Serological Transplant Diagnostics Market Size (US$ Mn) Analysis 2016–2020 and Forecast 2021–2031, By Country
Table 31: MEA Serological Transplant Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2016-2031, By Product
Table 32: MEA Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Application
Table 33: MEA Serological Transplant Diagnostics Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016-2031, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Serological Transplant Diagnostics Market Volume (Units), 2016-2020
Figure 02: Global Serological Transplant Diagnostics Market Volume (Units) Forecast, 2021 – 2031
Figure 03: Serological Transplant Diagnostics, Pricing Analysis per unit (US$), in Global 2020
Figure 04: Serological Transplant Diagnostics, Pricing Forecast per unit (US$), in Global 2031
Figure 05: Global Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016-2020
Figure 06: Global Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021 – 2031
Figure 07: Global Serological Transplant Diagnostics Market Absolute $ Opportunity, 2020 - 2031
Figure 08: Global Serological Transplant Diagnostics Market Share Analysis (%), By Product, 2021 & 2031
Figure 09: Global Serological Transplant Diagnostics Market Y-o-Y Analysis (%), By Product, 2021 – 2031
Figure 10: Global Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021 – 2031
Figure 11: Global Serological Transplant Diagnostics Market Share Analysis (%), By Application, 2021 & 2031
Figure 12: Global Serological Transplant Diagnostics Market Y-o-Y Analysis (%), By Application, 2021 – 2031
Figure 13: Global Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021 – 2031
Figure 14: Global Serological Transplant Diagnostics Market Share Analysis (%), By Distribution Channel, 2021 & 2031
Figure 15: Global Serological Transplant Diagnostics Market Y-o-Y Analysis (%), By Distribution Channel, 2021 – 2031
Figure 16: Global Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021 – 2031
Figure 17: Global Serological Transplant Diagnostics Market Share Analysis (%) By Region, 2021 & 2031
Figure 18: Global Serological Transplant Diagnostics Market Y-o-Y Growth (%) By Region, 2021–2031
Figure 19: Global Serological Transplant Diagnostics Market Attractiveness Analysis by Region, 2021–2031
Figure 20: North America Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016–2020
Figure 21: North America Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021–2031
Figure 22: North America Serological Transplant Diagnostics Market Attractiveness Analysis by Country, 2021–2031
Figure 23: North America Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021–2031
Figure 24: North America Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021–2031
Figure 25: North America Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 26: Latin America Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016–2020
Figure 27: Latin America Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021–2031
Figure 28: Latin America Serological Transplant Diagnostics Market Attractiveness Analysis by Country, 2021–2031
Figure 29: Latin America Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021–2031
Figure 30: Latin America Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021–2031
Figure 31: Latin America Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 32: Europe Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016–2020
Figure 33: Europe Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021–2031
Figure 34: Europe Serological Transplant Diagnostics Market Attractiveness Analysis by Country, 2021–2031
Figure 35: Europe Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021–2031
Figure 36: Europe Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021–2031
Figure 37: Europe Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 38: East Asia Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016–2020
Figure 39: East Asia Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021–2031
Figure 40: East Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Country, 2021–2031
Figure 41: East Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021–2031
Figure 42: East Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021–2031
Figure 43: East Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 44: South Asia Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016–2020
Figure 45: South Asia Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021–2031
Figure 46: South Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Country, 2021–2031
Figure 47: South Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021–2031
Figure 48: South Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021–2031
Figure 49: South Asia Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 50: Oceania Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016–2020
Figure 51: Oceania Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021–2031
Figure 52: Oceania Serological Transplant Diagnostics Market Attractiveness Analysis by Country, 2021–2031
Figure 53: Oceania Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021–2031
Figure 54: Oceania Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021–2031
Figure 55: Oceania Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 56: MEA Serological Transplant Diagnostics Market Value Analysis (US$ Mn), 2016–2020
Figure 57: MEA Serological Transplant Diagnostics Market Value Forecast (US$ Mn), 2021–2031
Figure 58: MEA Serological Transplant Diagnostics Market Attractiveness Analysis by Country, 2021–2031
Figure 59: MEA Serological Transplant Diagnostics Market Attractiveness Analysis by Product, 2021–2031
Figure 60: MEA Serological Transplant Diagnostics Market Attractiveness Analysis by Application, 2021–2031
Figure 61: MEA Serological Transplant Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021–2031
Figure 62: US. Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 63: US. Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 64: US. Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 65: Global Vs. U.S. Growth Comparison
Figure 66: Canada Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 67: Canada Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 68: Canada Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 69: Global Vs. Canada Growth Comparison
Figure 70: Brazil Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 71: Brazil Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 72: Brazil Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 73: Global Vs. Brazil Growth Comparison
Figure 74: Mexico Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 75: Mexico Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 76: Mexico Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 77: Global Vs. Mexico Growth Comparison
Figure 78: Argentina Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 79: Argentina Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 80: Argentina Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 81: Global Vs. Argentina Growth Comparison
Figure 82: Germany Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 83: Germany Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 84: Germany Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 85: Global Vs. Germany Growth Comparison
Figure 86: Italy Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 87: Italy Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 88: Italy Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 89: Global Vs. Italy Growth Comparison
Figure 90: France Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 91: France Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 92: France Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 93: Global Vs. France Growth Comparison
Figure 94: U.K. Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 95: U.K. Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 96: U.K. Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 97: Global Vs. U.K. Growth Comparison
Figure 98: Spain Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 99: Spain Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 100: Spain Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 101: Global Vs. Spain Growth Comparison
Figure 102: BENELUX Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 103: BENELUX Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 104: BENELUX Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2020 (E)
Figure 105: Global Vs. BENELUX Growth Comparison
Figure 106: Russia Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 107: Russia Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 108: Russia Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 109: Global Vs. Russia Growth Comparison
Figure 110: India Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 111: India Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 112: India Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 113: Global Vs. India Growth Comparison
Figure 114: Thailand Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 115: Thailand Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 116: Thailand Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 117: Global Vs. Thailand Growth Comparison
Figure 118: Malaysia Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 119: Malaysia Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 120: Malaysia Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2020 (E)
Figure 121: Global Vs. Malaysia Growth Comparison
Figure 122: China Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 123: China Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 124: China Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 125: Global Vs. China Growth Comparison
Figure 126: Japan Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 127: Japan Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 128: Japan Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 129: Global Vs. Japan Growth Comparison
Figure 130: South Korea Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 131: South Korea Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 132: South Korea Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 133: Global Vs. South Korea Growth Comparison
Figure 134: Australia Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 135: Australia Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 136: Australia Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 137: Global Vs. Australia Growth Comparison
Figure 138: New Zealand Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 139: New Zealand Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 140: New Zealand Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 141: Global Vs. New Zealand Growth Comparison
Figure 142: GCC Countries Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 143: GCC Countries Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 144: GCC Countries Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 145: Global Vs. GCC Growth Comparison
Figure 146: Turkey Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 147: Turkey Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 148: Turkey Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 149: Global Vs. Turkey Growth Comparison
Figure 150: South Africa Serological Transplant Diagnostics Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 151: South Africa Serological Transplant Diagnostics Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 152: South Africa Serological Transplant Diagnostics Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 153: Global Vs. South Africa Growth Comparison
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Which are the top companies operating in the market?
Some of the top companies providing serological transplant diagnostic equipment are Immucor Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., and ThermoFisher Scientific Inc.
Which are some of the lucrative markets for serological transplant diagnostics?
The United States, Canada, China, Germany, The United Kingdom, Japan, France, and a few others are lucrative markets for serological transplant diagnostics, and are expected to dominate throughout the forecast period.
Which is a highly sought-after product for serological transplant diagnostics?
Presently, reagents & accessories are the mostly sought-after in terms of product, and are expected to keep leading over the forecast period as well.
Serological Transplant Diagnostics Market